Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Carcinoma, Non-Small-Cell Lung | 45 | 2024 | 5379 | 2.670 |
Why?
|
Lung Neoplasms | 69 | 2024 | 13446 | 2.620 |
Why?
|
Quinazolines | 27 | 2019 | 1366 | 2.130 |
Why?
|
Protein Kinase Inhibitors | 41 | 2024 | 5691 | 1.900 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 7 | 2019 | 130 | 1.700 |
Why?
|
Drug Resistance, Neoplasm | 23 | 2024 | 5333 | 1.360 |
Why?
|
Quinazolinones | 4 | 2021 | 219 | 1.300 |
Why?
|
Mutation | 50 | 2024 | 30192 | 1.200 |
Why?
|
Antineoplastic Agents | 30 | 2024 | 13631 | 1.070 |
Why?
|
Apoptosis | 21 | 2024 | 9505 | 1.040 |
Why?
|
Receptor Protein-Tyrosine Kinases | 15 | 2024 | 1621 | 0.980 |
Why?
|
Pyrazoles | 11 | 2024 | 2031 | 0.960 |
Why?
|
Leukemia, Myeloid, Acute | 7 | 2021 | 3637 | 0.900 |
Why?
|
Lactams | 2 | 2024 | 159 | 0.900 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2536 | 0.740 |
Why?
|
Mutagenesis, Insertional | 5 | 2021 | 662 | 0.720 |
Why?
|
Aminopyridines | 2 | 2024 | 576 | 0.720 |
Why?
|
Molecular Targeted Therapy | 7 | 2024 | 2823 | 0.720 |
Why?
|
Cell Line, Tumor | 39 | 2024 | 17060 | 0.700 |
Why?
|
Exons | 11 | 2023 | 2393 | 0.700 |
Why?
|
Adenocarcinoma | 18 | 2020 | 6360 | 0.690 |
Why?
|
Benzene Derivatives | 1 | 2019 | 51 | 0.670 |
Why?
|
Alternative Splicing | 3 | 2020 | 1103 | 0.640 |
Why?
|
Styrenes | 1 | 2018 | 23 | 0.620 |
Why?
|
Genes, erbB-1 | 4 | 2019 | 161 | 0.620 |
Why?
|
Alkynes | 1 | 2019 | 326 | 0.600 |
Why?
|
Cytidine Deaminase | 1 | 2020 | 249 | 0.600 |
Why?
|
Janus Kinase 2 | 4 | 2022 | 562 | 0.560 |
Why?
|
Proto-Oncogene Proteins | 10 | 2017 | 4520 | 0.510 |
Why?
|
CCAAT-Binding Factor | 1 | 2015 | 21 | 0.490 |
Why?
|
HL-60 Cells | 5 | 2024 | 364 | 0.490 |
Why?
|
Drug Screening Assays, Antitumor | 7 | 2024 | 715 | 0.470 |
Why?
|
Pyridines | 8 | 2017 | 2885 | 0.440 |
Why?
|
Apoptosis Regulatory Proteins | 2 | 2010 | 1150 | 0.430 |
Why?
|
Oncogene Proteins, Fusion | 7 | 2024 | 1609 | 0.390 |
Why?
|
Cell Differentiation | 7 | 2021 | 11639 | 0.360 |
Why?
|
Receptor, erbB-2 | 3 | 2022 | 2592 | 0.350 |
Why?
|
Chromans | 1 | 2010 | 116 | 0.350 |
Why?
|
Benzopyrans | 1 | 2010 | 62 | 0.350 |
Why?
|
Transcription Factors | 5 | 2023 | 12129 | 0.340 |
Why?
|
Myeloproliferative Disorders | 3 | 2022 | 615 | 0.340 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2010 | 127 | 0.330 |
Why?
|
Nitrophenols | 1 | 2010 | 169 | 0.330 |
Why?
|
Sesquiterpenes | 1 | 2010 | 175 | 0.330 |
Why?
|
beta Catenin | 1 | 2014 | 1046 | 0.320 |
Why?
|
Structure-Activity Relationship | 7 | 2024 | 3049 | 0.320 |
Why?
|
Transcriptional Activation | 5 | 2021 | 1743 | 0.320 |
Why?
|
Biomimetic Materials | 1 | 2010 | 170 | 0.300 |
Why?
|
Erythroid Cells | 1 | 2010 | 237 | 0.300 |
Why?
|
Sequence Deletion | 2 | 2013 | 1494 | 0.290 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2024 | 452 | 0.280 |
Why?
|
Xenograft Model Antitumor Assays | 8 | 2022 | 3604 | 0.280 |
Why?
|
Sulfonamides | 2 | 2022 | 1979 | 0.270 |
Why?
|
Humans | 98 | 2024 | 765926 | 0.260 |
Why?
|
DNA | 1 | 2020 | 7193 | 0.260 |
Why?
|
Molecular Structure | 5 | 2024 | 1880 | 0.260 |
Why?
|
Lung | 5 | 2024 | 10046 | 0.260 |
Why?
|
Mice | 29 | 2024 | 81782 | 0.260 |
Why?
|
Taxoids | 1 | 2009 | 665 | 0.250 |
Why?
|
bcl-X Protein | 2 | 2024 | 412 | 0.250 |
Why?
|
Animals | 36 | 2024 | 168735 | 0.240 |
Why?
|
Gene Expression Profiling | 4 | 2024 | 9525 | 0.240 |
Why?
|
Biphenyl Compounds | 1 | 2010 | 1019 | 0.240 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 3 | 2022 | 1407 | 0.230 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2020 | 904 | 0.230 |
Why?
|
Cyclins | 1 | 2006 | 598 | 0.230 |
Why?
|
Protein-Tyrosine Kinases | 7 | 2019 | 2423 | 0.230 |
Why?
|
Acrylamides | 3 | 2019 | 259 | 0.210 |
Why?
|
Pyrogallol | 1 | 2022 | 8 | 0.210 |
Why?
|
Computer Simulation | 1 | 2016 | 6251 | 0.200 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2023 | 2838 | 0.200 |
Why?
|
Drug Tolerance | 1 | 2024 | 365 | 0.200 |
Why?
|
Leukemia, Neutrophilic, Chronic | 1 | 2002 | 14 | 0.200 |
Why?
|
Up-Regulation | 6 | 2021 | 4130 | 0.200 |
Why?
|
Gene Expression Regulation, Neoplastic | 7 | 2024 | 8603 | 0.200 |
Why?
|
Lactams, Macrocyclic | 1 | 2024 | 318 | 0.200 |
Why?
|
Granulocytes | 2 | 2018 | 548 | 0.190 |
Why?
|
Membrane Proteins | 2 | 2010 | 7847 | 0.190 |
Why?
|
Calpain | 1 | 2002 | 146 | 0.190 |
Why?
|
Cell Proliferation | 9 | 2023 | 10426 | 0.190 |
Why?
|
Fibroblast Growth Factor 9 | 1 | 2021 | 13 | 0.190 |
Why?
|
HSP90 Heat-Shock Proteins | 2 | 2018 | 422 | 0.190 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 3 | 2021 | 287 | 0.180 |
Why?
|
Epithelial-Mesenchymal Transition | 3 | 2023 | 750 | 0.180 |
Why?
|
Peroxiredoxins | 1 | 2021 | 50 | 0.180 |
Why?
|
Histone Acetyltransferases | 1 | 2023 | 332 | 0.180 |
Why?
|
Mice, Transgenic | 5 | 2024 | 9541 | 0.180 |
Why?
|
Interleukin-6 | 2 | 2024 | 3225 | 0.180 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2021 | 317 | 0.180 |
Why?
|
Models, Biological | 2 | 2016 | 9443 | 0.180 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2024 | 10727 | 0.180 |
Why?
|
Peptide Library | 2 | 2012 | 351 | 0.170 |
Why?
|
Proto-Oncogene Proteins c-akt | 4 | 2022 | 2455 | 0.170 |
Why?
|
STAT3 Transcription Factor | 1 | 2024 | 871 | 0.170 |
Why?
|
Indolizines | 1 | 2019 | 29 | 0.170 |
Why?
|
Aniline Compounds | 3 | 2019 | 1076 | 0.160 |
Why?
|
Gene Rearrangement | 4 | 2020 | 1143 | 0.160 |
Why?
|
Blotting, Western | 6 | 2015 | 5019 | 0.160 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2021 | 352 | 0.160 |
Why?
|
Gene Deletion | 1 | 2007 | 2667 | 0.160 |
Why?
|
Genes, Neoplasm | 1 | 2020 | 369 | 0.150 |
Why?
|
Cytoskeletal Proteins | 1 | 2024 | 1322 | 0.150 |
Why?
|
Proto-Oncogene Proteins c-met | 4 | 2015 | 561 | 0.150 |
Why?
|
Signal Transduction | 6 | 2023 | 23597 | 0.150 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 798 | 0.150 |
Why?
|
Epithelial Cells | 1 | 2010 | 3684 | 0.150 |
Why?
|
Enzyme Inhibitors | 3 | 2021 | 3716 | 0.150 |
Why?
|
Leukopoiesis | 1 | 2018 | 54 | 0.150 |
Why?
|
Gene Expression Regulation, Leukemic | 3 | 2021 | 657 | 0.150 |
Why?
|
Myeloid Cells | 3 | 2021 | 838 | 0.150 |
Why?
|
NAD | 1 | 2021 | 618 | 0.140 |
Why?
|
Base Sequence | 5 | 2017 | 12405 | 0.140 |
Why?
|
Trans-Activators | 3 | 2017 | 2848 | 0.140 |
Why?
|
Salicylamides | 1 | 2016 | 31 | 0.140 |
Why?
|
Organophosphorus Compounds | 1 | 2018 | 209 | 0.140 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2021 | 1440 | 0.140 |
Why?
|
Embolism, Air | 1 | 2017 | 111 | 0.140 |
Why?
|
4-Butyrolactone | 1 | 2016 | 60 | 0.130 |
Why?
|
Carbazoles | 1 | 2018 | 229 | 0.130 |
Why?
|
Microtubule-Associated Proteins | 1 | 2021 | 1065 | 0.130 |
Why?
|
Piperidines | 3 | 2018 | 1664 | 0.130 |
Why?
|
Thymidine Phosphorylase | 2 | 2008 | 16 | 0.130 |
Why?
|
Liver Neoplasms | 1 | 2012 | 4349 | 0.130 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2024 | 4044 | 0.130 |
Why?
|
Phosphorylation | 9 | 2020 | 8279 | 0.130 |
Why?
|
Gene Amplification | 3 | 2015 | 1088 | 0.120 |
Why?
|
RNA Splicing | 1 | 2020 | 902 | 0.120 |
Why?
|
Tumor Burden | 3 | 2021 | 1888 | 0.120 |
Why?
|
Mixed Function Oxygenases | 1 | 2016 | 265 | 0.120 |
Why?
|
Brain Neoplasms | 3 | 2022 | 9065 | 0.120 |
Why?
|
Radiation-Sensitizing Agents | 1 | 2016 | 347 | 0.110 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2016 | 446 | 0.110 |
Why?
|
Fatal Outcome | 3 | 2017 | 1835 | 0.110 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2016 | 4342 | 0.110 |
Why?
|
Drug Design | 2 | 2016 | 1039 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2020 | 2877 | 0.110 |
Why?
|
Genes, Reporter | 2 | 2015 | 1524 | 0.110 |
Why?
|
Autopsy | 1 | 2017 | 1011 | 0.110 |
Why?
|
Luciferases | 1 | 2015 | 712 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2206 | 0.110 |
Why?
|
Transcription, Genetic | 5 | 2021 | 7599 | 0.110 |
Why?
|
Cell Survival | 3 | 2021 | 5745 | 0.100 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2020 | 2057 | 0.100 |
Why?
|
Drug Synergism | 2 | 2016 | 1751 | 0.100 |
Why?
|
Cell Line | 5 | 2021 | 15540 | 0.100 |
Why?
|
Small Molecule Libraries | 1 | 2018 | 740 | 0.100 |
Why?
|
Protein Stability | 1 | 2014 | 576 | 0.100 |
Why?
|
Disease Models, Animal | 6 | 2021 | 18292 | 0.100 |
Why?
|
ATP Citrate (pro-S)-Lyase | 1 | 2012 | 21 | 0.100 |
Why?
|
Doxycycline | 1 | 2014 | 348 | 0.100 |
Why?
|
Tretinoin | 1 | 2015 | 524 | 0.100 |
Why?
|
Neutrophils | 2 | 2002 | 3769 | 0.100 |
Why?
|
Hepatocyte Nuclear Factor 3-beta | 1 | 2012 | 64 | 0.100 |
Why?
|
Hematopoiesis | 2 | 2018 | 2060 | 0.100 |
Why?
|
Promoter Regions, Genetic | 3 | 2021 | 5784 | 0.100 |
Why?
|
Mutation, Missense | 2 | 2014 | 2589 | 0.100 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2018 | 1331 | 0.100 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 4 | 2019 | 11858 | 0.100 |
Why?
|
DNA Methylation | 3 | 2021 | 4424 | 0.090 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 1117 | 0.090 |
Why?
|
K562 Cells | 2 | 2010 | 644 | 0.090 |
Why?
|
Phosphatidic Acids | 1 | 2010 | 50 | 0.090 |
Why?
|
Immunohistochemistry | 5 | 2018 | 11030 | 0.090 |
Why?
|
E2F Transcription Factors | 1 | 2011 | 269 | 0.090 |
Why?
|
Tumor Microenvironment | 3 | 2022 | 3940 | 0.090 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 2945 | 0.090 |
Why?
|
Fluorescent Antibody Technique | 1 | 2015 | 2470 | 0.090 |
Why?
|
Tumor Cells, Cultured | 2 | 2016 | 6101 | 0.090 |
Why?
|
Anti-Retroviral Agents | 1 | 2020 | 1786 | 0.090 |
Why?
|
Dual Specificity Phosphatase 6 | 1 | 2010 | 12 | 0.090 |
Why?
|
MAP Kinase Signaling System | 3 | 2016 | 1489 | 0.090 |
Why?
|
Pyrimidines | 2 | 2021 | 3049 | 0.080 |
Why?
|
Cell Growth Processes | 2 | 2013 | 380 | 0.080 |
Why?
|
Purines | 2 | 2024 | 616 | 0.080 |
Why?
|
Proto-Oncogene Protein c-ets-1 | 1 | 2010 | 65 | 0.080 |
Why?
|
Alkanesulfonic Acids | 1 | 2012 | 199 | 0.080 |
Why?
|
Glioblastoma | 2 | 2022 | 3458 | 0.080 |
Why?
|
Etoposide | 1 | 2011 | 636 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3592 | 0.080 |
Why?
|
High-Throughput Screening Assays | 1 | 2015 | 938 | 0.080 |
Why?
|
Female | 28 | 2021 | 396141 | 0.080 |
Why?
|
Head and Neck Neoplasms | 1 | 2023 | 2924 | 0.080 |
Why?
|
Mutant Proteins | 2 | 2010 | 486 | 0.080 |
Why?
|
Neoplasm Staging | 4 | 2021 | 11196 | 0.080 |
Why?
|
Cells, Cultured | 3 | 2020 | 18962 | 0.080 |
Why?
|
Magnetic Resonance Spectroscopy | 2 | 2010 | 3678 | 0.080 |
Why?
|
Carrier Proteins | 2 | 2012 | 4909 | 0.080 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3661 | 0.080 |
Why?
|
Polycythemia Vera | 1 | 2010 | 160 | 0.080 |
Why?
|
Mitochondria | 2 | 2021 | 3669 | 0.070 |
Why?
|
NF-kappa B | 1 | 2016 | 2492 | 0.070 |
Why?
|
Glucose Transporter Type 4 | 1 | 2008 | 241 | 0.070 |
Why?
|
Thoracic Wall | 1 | 2009 | 196 | 0.070 |
Why?
|
Aged | 16 | 2021 | 171163 | 0.070 |
Why?
|
Mice, Nude | 3 | 2021 | 3608 | 0.070 |
Why?
|
Oleanolic Acid | 1 | 2007 | 43 | 0.070 |
Why?
|
Proteins | 1 | 2002 | 5994 | 0.070 |
Why?
|
Pulmonary Alveoli | 1 | 2010 | 665 | 0.070 |
Why?
|
DNA Mutational Analysis | 2 | 2013 | 4111 | 0.070 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 613 | 0.070 |
Why?
|
Down-Regulation | 2 | 2012 | 2925 | 0.070 |
Why?
|
Survival Rate | 3 | 2017 | 12822 | 0.070 |
Why?
|
Male | 21 | 2020 | 363815 | 0.070 |
Why?
|
Cyclin D | 1 | 2006 | 70 | 0.070 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2270 | 0.070 |
Why?
|
Thoracic Surgery, Video-Assisted | 1 | 2009 | 290 | 0.070 |
Why?
|
Fluorocarbons | 1 | 2012 | 499 | 0.070 |
Why?
|
Translocation, Genetic | 1 | 2012 | 1393 | 0.070 |
Why?
|
Middle Aged | 16 | 2019 | 223016 | 0.060 |
Why?
|
Tumor Suppressor Proteins | 1 | 2016 | 2795 | 0.060 |
Why?
|
Pneumothorax | 1 | 2009 | 392 | 0.060 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 2006 | 175 | 0.060 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2009 | 658 | 0.060 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2010 | 614 | 0.060 |
Why?
|
Oxygen | 1 | 2017 | 4246 | 0.060 |
Why?
|
Caspases | 2 | 1999 | 880 | 0.060 |
Why?
|
HEK293 Cells | 1 | 2014 | 4257 | 0.060 |
Why?
|
DNA, Neoplasm | 2 | 2013 | 1739 | 0.060 |
Why?
|
Transfection | 3 | 2009 | 5738 | 0.060 |
Why?
|
Aged, 80 and over | 8 | 2018 | 59496 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6612 | 0.060 |
Why?
|
Models, Structural | 1 | 2005 | 338 | 0.060 |
Why?
|
Milk Proteins | 1 | 2005 | 161 | 0.060 |
Why?
|
Cycloheximide | 2 | 2002 | 339 | 0.060 |
Why?
|
Caspase 3 | 3 | 2002 | 731 | 0.060 |
Why?
|
STAT5 Transcription Factor | 1 | 2005 | 268 | 0.060 |
Why?
|
Leukemia, Myeloid | 1 | 2007 | 695 | 0.060 |
Why?
|
Interleukin-3 | 1 | 2005 | 423 | 0.060 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 2024 | 70 | 0.060 |
Why?
|
Purine Nucleotides | 1 | 2024 | 27 | 0.060 |
Why?
|
Genotype | 3 | 2015 | 13026 | 0.060 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2006 | 429 | 0.060 |
Why?
|
Amino Acid Sequence | 4 | 2021 | 13398 | 0.050 |
Why?
|
Flavonoids | 1 | 2006 | 445 | 0.050 |
Why?
|
Alopecia | 1 | 2007 | 415 | 0.050 |
Why?
|
Cyclin-Dependent Kinases | 1 | 2006 | 659 | 0.050 |
Why?
|
Stromal Cells | 1 | 2008 | 1332 | 0.050 |
Why?
|
Tyrphostins | 1 | 2022 | 63 | 0.050 |
Why?
|
Solitary Pulmonary Nodule | 1 | 2006 | 280 | 0.050 |
Why?
|
MAP Kinase Kinase 4 | 1 | 2022 | 146 | 0.050 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2002 | 62 | 0.050 |
Why?
|
RNA, Neoplasm | 1 | 2005 | 745 | 0.050 |
Why?
|
Retrospective Studies | 9 | 2019 | 81537 | 0.050 |
Why?
|
Proto-Oncogenes | 1 | 2022 | 320 | 0.050 |
Why?
|
Doxorubicin | 2 | 2019 | 2226 | 0.050 |
Why?
|
Poly Adenosine Diphosphate Ribose | 1 | 2021 | 51 | 0.050 |
Why?
|
Mice, Knockout | 2 | 2015 | 14450 | 0.050 |
Why?
|
Polyenes | 1 | 2021 | 68 | 0.050 |
Why?
|
Microscopy | 1 | 2006 | 900 | 0.050 |
Why?
|
Prognosis | 4 | 2016 | 29890 | 0.050 |
Why?
|
Adipocytes | 1 | 2008 | 1195 | 0.050 |
Why?
|
Erythroid Precursor Cells | 1 | 2021 | 211 | 0.050 |
Why?
|
Epoxy Compounds | 1 | 2021 | 137 | 0.040 |
Why?
|
Glucocorticoids | 1 | 2010 | 2155 | 0.040 |
Why?
|
Drug Interactions | 1 | 2005 | 1416 | 0.040 |
Why?
|
Follow-Up Studies | 4 | 2016 | 39228 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2021 | 361 | 0.040 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2021 | 432 | 0.040 |
Why?
|
Cell Transdifferentiation | 1 | 2021 | 186 | 0.040 |
Why?
|
Disease-Free Survival | 3 | 2017 | 6838 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2016 | 20133 | 0.040 |
Why?
|
Ethylnitrosourea | 1 | 2019 | 50 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2021 | 428 | 0.040 |
Why?
|
Point Mutation | 1 | 2005 | 1590 | 0.040 |
Why?
|
Rectal Neoplasms | 1 | 2008 | 1183 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2021 | 502 | 0.040 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2022 | 691 | 0.040 |
Why?
|
Piperazines | 1 | 2010 | 2546 | 0.040 |
Why?
|
Carcinoma | 1 | 2010 | 2311 | 0.040 |
Why?
|
Reoperation | 1 | 2009 | 4308 | 0.040 |
Why?
|
Alkylating Agents | 1 | 2019 | 133 | 0.040 |
Why?
|
Precursor Cells, B-Lymphoid | 1 | 2019 | 95 | 0.040 |
Why?
|
Oncogene Proteins | 1 | 2023 | 710 | 0.040 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 20690 | 0.040 |
Why?
|
Republic of Korea | 1 | 2020 | 583 | 0.040 |
Why?
|
Epigenesis, Genetic | 1 | 2012 | 3816 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2006 | 3796 | 0.040 |
Why?
|
Mucin-1 | 1 | 2023 | 535 | 0.040 |
Why?
|
Forensic Pathology | 1 | 2017 | 23 | 0.040 |
Why?
|
Cysteine Proteinase Inhibitors | 1 | 1998 | 185 | 0.040 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2017 | 2510 | 0.040 |
Why?
|
Endothelial Cells | 1 | 2010 | 3586 | 0.040 |
Why?
|
Cell Aggregation | 1 | 2017 | 238 | 0.030 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3249 | 0.030 |
Why?
|
Sequence Analysis, RNA | 1 | 2005 | 2036 | 0.030 |
Why?
|
Amino Acids | 1 | 2023 | 1709 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2021 | 1837 | 0.030 |
Why?
|
Succinate Dehydrogenase | 1 | 2017 | 148 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2021 | 1167 | 0.030 |
Why?
|
Nitriles | 1 | 2021 | 981 | 0.030 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2017 | 292 | 0.030 |
Why?
|
Molecular Dynamics Simulation | 1 | 2019 | 422 | 0.030 |
Why?
|
Mice, SCID | 1 | 2021 | 2626 | 0.030 |
Why?
|
Image Enhancement | 1 | 2006 | 2857 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2021 | 12768 | 0.030 |
Why?
|
Treatment Outcome | 7 | 2019 | 65194 | 0.030 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2017 | 238 | 0.030 |
Why?
|
Ligands | 1 | 2022 | 3272 | 0.030 |
Why?
|
Pyrroles | 1 | 2021 | 1119 | 0.030 |
Why?
|
Mutagenesis | 1 | 2019 | 1226 | 0.030 |
Why?
|
Cysteine Endopeptidases | 1 | 1998 | 542 | 0.030 |
Why?
|
Antibodies, Monoclonal | 3 | 2009 | 9239 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 3 | 2012 | 6503 | 0.030 |
Why?
|
Protein Conformation | 2 | 2013 | 3945 | 0.030 |
Why?
|
Gene Expression | 2 | 2020 | 7581 | 0.030 |
Why?
|
Leukemia | 1 | 2022 | 1522 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2017 | 1159 | 0.030 |
Why?
|
Molecular Sequence Data | 3 | 2013 | 17596 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2011 | 11895 | 0.030 |
Why?
|
Structural Homology, Protein | 1 | 2013 | 86 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2020 | 1775 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2005 | 4780 | 0.030 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2006 | 3360 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2006 | 3405 | 0.030 |
Why?
|
Indoles | 1 | 2021 | 1833 | 0.030 |
Why?
|
HeLa Cells | 1 | 2019 | 3070 | 0.030 |
Why?
|
Cell Count | 1 | 2017 | 1823 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2020 | 21069 | 0.030 |
Why?
|
Imaging, Three-Dimensional | 1 | 2006 | 4037 | 0.030 |
Why?
|
Biopsy | 1 | 2005 | 6766 | 0.030 |
Why?
|
Models, Molecular | 2 | 2013 | 5377 | 0.030 |
Why?
|
Protein Binding | 2 | 2017 | 9296 | 0.020 |
Why?
|
Oligopeptides | 1 | 1998 | 1193 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2021 | 6209 | 0.020 |
Why?
|
RNA-Binding Proteins | 1 | 2020 | 1882 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2009 | 10380 | 0.020 |
Why?
|
Activin Receptors, Type II | 1 | 2012 | 122 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2015 | 1750 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2020 | 2045 | 0.020 |
Why?
|
CpG Islands | 1 | 2016 | 1207 | 0.020 |
Why?
|
Immunoprecipitation | 1 | 2014 | 871 | 0.020 |
Why?
|
Esophageal Neoplasms | 1 | 2002 | 1659 | 0.020 |
Why?
|
Enzyme Activation | 3 | 2006 | 3583 | 0.020 |
Why?
|
Surface Plasmon Resonance | 1 | 2012 | 268 | 0.020 |
Why?
|
Genomic Instability | 1 | 2015 | 716 | 0.020 |
Why?
|
Phosphodiesterase I | 1 | 2010 | 6 | 0.020 |
Why?
|
Technology Transfer | 1 | 2011 | 41 | 0.020 |
Why?
|
Biotinylation | 1 | 2011 | 184 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 1999 | 2141 | 0.020 |
Why?
|
Prospective Studies | 4 | 2020 | 54807 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2020 | 2444 | 0.020 |
Why?
|
Lysophospholipase | 1 | 2010 | 65 | 0.020 |
Why?
|
Disease Progression | 1 | 2008 | 13614 | 0.020 |
Why?
|
Microarray Analysis | 1 | 2013 | 752 | 0.020 |
Why?
|
Adult | 8 | 2018 | 223088 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2008 | 9373 | 0.020 |
Why?
|
Receptors, Lysophosphatidic Acid | 1 | 2010 | 78 | 0.020 |
Why?
|
Oncogenes | 1 | 2016 | 1232 | 0.020 |
Why?
|
Genomics | 2 | 2018 | 5925 | 0.020 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2020 | 2897 | 0.020 |
Why?
|
Pyrophosphatases | 1 | 2010 | 143 | 0.020 |
Why?
|
Gene Silencing | 1 | 2016 | 1504 | 0.020 |
Why?
|
Bacteriophage T7 | 1 | 2011 | 174 | 0.020 |
Why?
|
Stereoisomerism | 1 | 2010 | 612 | 0.020 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 2010 | 205 | 0.020 |
Why?
|
Cricetulus | 1 | 2011 | 806 | 0.020 |
Why?
|
Isoenzymes | 1 | 2014 | 1688 | 0.020 |
Why?
|
Crystallography, X-Ray | 1 | 2013 | 1944 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2016 | 2213 | 0.020 |
Why?
|
CHO Cells | 1 | 2011 | 1372 | 0.020 |
Why?
|
Caspase 9 | 2 | 1999 | 184 | 0.020 |
Why?
|
DNA-Binding Proteins | 1 | 2005 | 9600 | 0.020 |
Why?
|
Caspase 8 | 2 | 1999 | 198 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2007 | 16039 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2009 | 3498 | 0.020 |
Why?
|
3T3-L1 Cells | 1 | 2008 | 206 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2009 | 651 | 0.020 |
Why?
|
Genes, abl | 1 | 2007 | 69 | 0.020 |
Why?
|
Cricetinae | 1 | 2011 | 2412 | 0.020 |
Why?
|
Gene Dosage | 1 | 2012 | 1213 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2012 | 1601 | 0.020 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 2007 | 141 | 0.020 |
Why?
|
Feedback, Physiological | 1 | 2010 | 480 | 0.020 |
Why?
|
Recombinant Proteins | 2 | 2012 | 6491 | 0.020 |
Why?
|
Melanoma, Experimental | 1 | 2010 | 555 | 0.020 |
Why?
|
Multienzyme Complexes | 1 | 2010 | 663 | 0.020 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2010 | 634 | 0.020 |
Why?
|
Myeloid Progenitor Cells | 1 | 2007 | 112 | 0.020 |
Why?
|
Sequence Alignment | 1 | 2011 | 2172 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-4E | 1 | 2007 | 111 | 0.020 |
Why?
|
Genes, ras | 1 | 2009 | 656 | 0.020 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 2010 | 1527 | 0.020 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2011 | 878 | 0.020 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2006 | 47 | 0.020 |
Why?
|
Eukaryotic Initiation Factor-2 | 1 | 2007 | 177 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2017 | 3606 | 0.020 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2006 | 83 | 0.020 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2007 | 262 | 0.020 |
Why?
|
Algorithms | 1 | 2006 | 14064 | 0.020 |
Why?
|
Retroviridae | 1 | 2008 | 845 | 0.020 |
Why?
|
GATA1 Transcription Factor | 1 | 2006 | 306 | 0.010 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2007 | 637 | 0.010 |
Why?
|
Serine | 1 | 2008 | 825 | 0.010 |
Why?
|
Cytoplasm | 1 | 2008 | 1498 | 0.010 |
Why?
|
Cohort Studies | 1 | 2007 | 41680 | 0.010 |
Why?
|
Cell Cycle | 1 | 2012 | 2920 | 0.010 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2007 | 561 | 0.010 |
Why?
|
Biological Transport | 1 | 2008 | 2081 | 0.010 |
Why?
|
Plasmids | 1 | 2008 | 2267 | 0.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2017 | 3247 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 2006 | 2008 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2018 | 6542 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 4563 | 0.010 |
Why?
|
Appendicitis | 1 | 2008 | 680 | 0.010 |
Why?
|
Macrophages | 1 | 2016 | 5772 | 0.010 |
Why?
|
Protein Kinases | 1 | 2008 | 1611 | 0.010 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2006 | 685 | 0.010 |
Why?
|
RNA, Small Interfering | 1 | 2010 | 3419 | 0.010 |
Why?
|
Quinolines | 1 | 2006 | 769 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3599 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2007 | 2089 | 0.010 |
Why?
|
Mice, Inbred C57BL | 2 | 2010 | 22327 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2012 | 8522 | 0.010 |
Why?
|
Computational Biology | 1 | 2012 | 3562 | 0.010 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2006 | 1138 | 0.010 |
Why?
|
Smoking | 1 | 2017 | 9082 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2007 | 4851 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2006 | 3749 | 0.010 |
Why?
|
Peptides | 1 | 2011 | 4331 | 0.010 |
Why?
|
Affinity Labels | 1 | 1999 | 107 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 1999 | 187 | 0.010 |
Why?
|
Immunoenzyme Techniques | 1 | 2002 | 1695 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2007 | 3542 | 0.010 |
Why?
|
Medical Oncology | 1 | 2010 | 2339 | 0.010 |
Why?
|
Caspase 6 | 1 | 1998 | 15 | 0.010 |
Why?
|
Caspase 7 | 1 | 1998 | 51 | 0.010 |
Why?
|
Nuclear Matrix-Associated Proteins | 1 | 1998 | 38 | 0.010 |
Why?
|
Software | 1 | 2012 | 4462 | 0.010 |
Why?
|
Risk Assessment | 2 | 2011 | 24275 | 0.010 |
Why?
|
Superoxides | 1 | 1999 | 382 | 0.010 |
Why?
|
DNA Fragmentation | 1 | 1998 | 238 | 0.010 |
Why?
|
RNA Interference | 1 | 2006 | 2829 | 0.010 |
Why?
|
Antigens, Nuclear | 1 | 1998 | 182 | 0.010 |
Why?
|
Recurrence | 1 | 2009 | 8492 | 0.010 |
Why?
|
Homeostasis | 1 | 2008 | 3338 | 0.010 |
Why?
|
Jurkat Cells | 1 | 1998 | 738 | 0.010 |
Why?
|
Glucose | 1 | 2008 | 4335 | 0.010 |
Why?
|
Brain | 1 | 2022 | 27179 | 0.010 |
Why?
|
Immunoblotting | 1 | 1999 | 1643 | 0.010 |
Why?
|
Sex Factors | 1 | 2009 | 10611 | 0.010 |
Why?
|
Stem Cells | 1 | 2007 | 3537 | 0.010 |
Why?
|
Genome, Human | 1 | 2007 | 4443 | 0.010 |
Why?
|
Logistic Models | 1 | 2008 | 13273 | 0.010 |
Why?
|
Autoantigens | 1 | 1998 | 886 | 0.010 |
Why?
|
Phenotype | 1 | 2011 | 16714 | 0.010 |
Why?
|
Neoplasms | 1 | 2021 | 22340 | 0.010 |
Why?
|
Age Factors | 1 | 2009 | 18382 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2006 | 14643 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 18074 | 0.010 |
Why?
|
Survival Analysis | 1 | 2002 | 10086 | 0.000 |
Why?
|
Time Factors | 1 | 2009 | 40097 | 0.000 |
Why?
|
Flow Cytometry | 1 | 1998 | 5880 | 0.000 |
Why?
|
Cell Cycle Proteins | 1 | 1998 | 3431 | 0.000 |
Why?
|
Nuclear Proteins | 1 | 1998 | 5782 | 0.000 |
Why?
|
Young Adult | 1 | 2009 | 59857 | 0.000 |
Why?
|
Adolescent | 1 | 2009 | 88811 | 0.000 |
Why?
|